
Theme 2
Cell-free Synthetic Biology
We build high-yielding cell-free systems from diverse bacteria to make peptides, proteins and small molecules, and to prototype pathways fast.
Research theme 1
We engineer Streptomyces bacteria to discover and make new bioactive molecules.
Bacteria make chemicals that become medicines, crop protection agents and industrial chemicals. Their genes sit together in biosynthetic gene clusters, and most clusters stay silent in the laboratory. We switch them on, work out what they make and engineer the pathways to make more.
We work mainly in Streptomyces venezuelae, a fast-growing bacterium that suits synthetic biology. We ask basic questions, such as how a pathway is regulated and how a single enzyme works. We then apply the answers to enzyme discovery, pathway engineering and the production of high-value chemicals and new biotherapeutics.
Our tools include CRISPR-Cas9, heterologous expression hosts and pathway refactoring. We aim these tools at global challenges: antimicrobial resistance, sustainable crop protection and the replacement of petrochemical synthesis with biological routes.
Recent success: we expressed the acfXODCP genes from S. venezuelae ATCC 10712 in S. coelicolor M1152 and isolated arcyriaflavin F, a C-5/C-5' dihydroxylated indolocarbazole. The enzyme AcfX adds both hydroxyl groups.
Sources: NCBI RefSeq NC_018750.1 (opens in a new tab) and Lai et al., ChemBioChem (2024) (opens in a new tab).
The photographs show the steps from a harvested cell pellet to a purified natural product.




Photographs from the bench: reporter assays, marine bacteria, extraction and analysis.




Each entry links to the paper, its Altmetric record and a live citation count.
ChemRxiv (2026) Preprint - https://doi.org/10.26434/chemrxiv.15004675/v1
ChemBioChem (2024) 25:e202400357

Nat. Prod. Rep. (2023) 40:228-236

ACS Chemical Biology (2021) 16(11):2116

Nature (2017) 543:78-82

Synth. Biol. (2021) 6:ysab021
Microb. Cell Factories (2021) 20: 116
ACS Synth. Biol. (2016) 5:1059-1069
New Biotechnology (2014) 31:553-61
PNAS (2013) 110:14906-14911
Journal of Biological Chemistry (2013) 288:297-305
Biochemical Society Transactions (2012) 40: 581-586
Encyclopedia of Molecular Cell Biology and Molecular Medicine, Wiley (2014)

Theme 2
We build high-yielding cell-free systems from diverse bacteria to make peptides, proteins and small molecules, and to prototype pathways fast.

Theme 3
We use cell-free systems to measure how antibiotics work and how bacteria resist them, and to test alternative antimicrobials, with the UK Health Security Agency.
We welcome enquiries from prospective students and fellows, and from industry and public-sector partners.
Past and current funders
Leverhulme Trust (opens in a new tab)
BBSRC (opens in a new tab)
Royal Society (opens in a new tab)
Wellcome Trust (opens in a new tab)
FAPESP (opens in a new tab)
Biochemical Society (opens in a new tab)
Syngenta (opens in a new tab)
Sanofi (opens in a new tab)
UKRI (opens in a new tab)
Horizon Europe (opens in a new tab)